2017
DOI: 10.1016/j.amjcard.2016.05.029
|View full text |Cite
|
Sign up to set email alerts
|

Interatrial Block to Guide the Thromboembolic Prevention Strategy: Should It be the Next Step?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
10
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 8 publications
0
10
0
1
Order By: Relevance
“…It is necessary to emphasize that the vast majority of patients with A‐IAB have at the same time a CHA 2 DS 2 ‐VASc score ≥2 and therefore, if AF is documented, the patients would fulfil conventional indications for oral anticoagulation. Consequently, one could argue that given the association of A‐IAB with AF, there is a possibility that many strokes would be avoided if patients with high CHA 2 DS 2 ‐VASc score and A‐IAB, were treated with anticoagulation regardless of the documented evidence of AF (Chhabra & Gowdar, ; Hughes & Worrall, ; Martínez‐Sellés, Fernández Lozano, Baranchuk, Bayes‐Genis, & Bayés de Luna, ). Of course, the possible benefits derived from this hypothesis; need to be counter balanced with the possible side effects of anticoagulation.…”
Section: The Main Aim Should Be To Reduce the Risk Of Strokementioning
confidence: 99%
“…It is necessary to emphasize that the vast majority of patients with A‐IAB have at the same time a CHA 2 DS 2 ‐VASc score ≥2 and therefore, if AF is documented, the patients would fulfil conventional indications for oral anticoagulation. Consequently, one could argue that given the association of A‐IAB with AF, there is a possibility that many strokes would be avoided if patients with high CHA 2 DS 2 ‐VASc score and A‐IAB, were treated with anticoagulation regardless of the documented evidence of AF (Chhabra & Gowdar, ; Hughes & Worrall, ; Martínez‐Sellés, Fernández Lozano, Baranchuk, Bayes‐Genis, & Bayés de Luna, ). Of course, the possible benefits derived from this hypothesis; need to be counter balanced with the possible side effects of anticoagulation.…”
Section: The Main Aim Should Be To Reduce the Risk Of Strokementioning
confidence: 99%
“…Advanced IAB (a‐IAB) presents biphasic morphology in the inferior leads (II, III, aVF) while partial IAB (p‐IAB) does not present a negative component in the inferior leads. Recently, several studies identified IAB as a reliable predictor for new onset of atrial fibrillation (AF), AF recurrences following pulmonary vein isolation and pharmacological cardioversion and increased risk of ischemic stroke …”
Section: Introductionmentioning
confidence: 99%
“…Recently, several studies identified IAB as a reliable predictor for new onset of atrial fibrillation (AF), [6][7][8] AF recurrences following pulmonary vein isolation 9 and pharmacological cardioversion 10 and increased risk of ischemic stroke. [11][12][13][14] Our aim in the present study was to investigate the prevalence of IAB in patients presenting with acute ST-segment elevation myocardial infarction (STEMI), its relation with specific culprit coronary artery lesion and its ability to predict new onset AF at 12 months follow-up.…”
Section: Introductionmentioning
confidence: 99%
“…2 Bay es's syndrome is the association of A-IAB with supraventricular tachyarrhythmias, more specifically AF. [2][3][4] It is diagnosed when the P-wave duration is longer than 120 msec and there is a biphasic morphology in leads II, III, and aVF. Interatrial block may (or may not) be associated with LA enlargement, and represents LA electromechanical dysfunction.…”
mentioning
confidence: 99%